The current earnings forecast score of Lifeward Ltd is 8.00, ranking 69 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 4.50, with a high of 10.00 and a low of 1.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
20.000
Target Price
+181.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Lifeward Ltd
LFWD
2
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Lifeward Ltd's expected revenue for the next quarter?
Lifeward Ltd's expected revenue is 6.53M.
What is Lifeward Ltd's price target?
Analysts forecast that Lifeward Ltd's price target is USD 4.50, with the highest forecast at USD 10.00 and the lowest forecast at USD 1.00.
How have Lifeward LtdLFWD's recent earnings per share performed?
The market expectation was USD -6.70, while Lifeward LtdLFWD's earnings per share (EPS) for the previous quarter was USD -3.59. EPS for the next quarter is expected at USD -1.34.
What is the analyst rating for Lifeward Ltd?
Based on the ratings of Lifeward Ltd's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.